01.02.2011 | Original Article
The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study
Erschienen in: Neurological Sciences | Ausgabe 1/2011
Einloggen, um Zugang zu erhalten